Evolutionary diversification and succession of soil huge phages in glacier foreland
Microbiome · 21.01.2025 · 13 (1)
DOI: 10.1186/s40168-024-02017-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiome, online erschienen am 21.01.2025. Verfasst von Hu Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Urban Environment and Health, Ningbo Observation and Research Station, Institute of Urban Environment, Chinese Academy of Sciences,…. Hauptthemen laut MEDLINE: Bacteriophages, Soil Microbiology, Ice Cover. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Second Tibetan Plateau Scientific Expedition and Research Program.
Abstract (Originalsprache)
BACKGROUND: Huge phages (genome size ≥ 200 kb) have been detected in diverse habitats worldwide, infecting a variety of prokaryotes. However, their evolution and adaptation strategy in soils remain poorly understood due to the scarcity of soil-derived genomes. RESULTS: Here, we conduct a size-fractioned ( 41 years) based on the macrodiveristy (interspecies diversity) analysis. A significant increase in the diversity of huge phages communities following glacier retreat were observed according to current database. The phages distributed across sites within late stage demonstrated a remarkable higher microdiversity (intraspecies diversity) compared to other geographic range such as the intra early stage, suggesting that glacial retreat is key drivers of the huge phage speciation. Alongside the shift in huge phage communities, we also noted an evolutionary and functional transition between the early and late stages. The identification of abundant CRISPR-Cas12 and type IV restriction-modification (RM) systems in huge phages indicates their complex mechanisms for adaptive immunity. CONCLUSIONS: Overall, this study unravels the importance of climate change in shaping the composition, evolution, and function of soil huge phage communities, and such further understanding of soil huge phages is vital for broader inclusion in soil ecosystem models. Video Abstract.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Urban Environment and Health, Ningbo Observation and Research Station, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen, 361021, China.
- University of Chinese Academy of Sciences, Beijing, 100049, China.
- CAS Key Laboratory of Mountain Surface Processes and Ecological Regulation, Institute of Mountain Hazards and Environment, Chinese Academy of Sciences, Chengdu, 610041, China.
- State Key Lab of Urban and Regional Ecology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing, 100085, China.
- Key Laboratory of Urban Environment and Health, Ningbo Observation and Research Station, Institute of Urban Environment, Chinese Academy of Sciences, Xiamen, 361021, China. jqsu@iue.ac.cn.
- University of Chinese Academy of Sciences, Beijing, 100049, China. jqsu@iue.ac.cn.
Förderung
- National Natural Science Foundation of China
- Second Tibetan Plateau Scientific Expedition and Research Program
Zitieren
APA
Liao, H., Li, J., Wang, Y. Z., Li, H., An, X. L., Wang, T., Chang, R. Y., Zhu, Y. G., & Su, J. Q. (2025). Evolutionary diversification and succession of soil huge phages in glacier foreland. Microbiome, 13(1). https://doi.org/10.1186/s40168-024-02017-2
Vancouver
Liao H, Li J, Wang YZ, Li H, An XL, Wang T, et al. Evolutionary diversification and succession of soil huge phages in glacier foreland. Microbiome. 2025;13(1). doi:10.1186/s40168-024-02017-2
BibTeX
@article{Liao2025,
author = {Liao, Hu and Li, Jian and Wang, Yan-Zi and Li, Hu and An, Xin-Li and Wang, Tao and Chang, Rui-Ying and Zhu, Yong-Guan and Su, Jian-Qiang},
title = {Evolutionary diversification and succession of soil huge phages in glacier foreland},
journal = {Microbiome},
year = {2025},
volume = {13},
number = {1},
doi = {10.1186/s40168-024-02017-2}
}
EUVIMED